Product Introduction:
Ilet Trio 0.2/500/2 Tablet is a triple drug combination used in the effective management of type 2 diabetes.
-
Metformin improves insulin sensitivity and lowers glucose production.
-
Glimepiride increases insulin secretion from the pancreas.
-
Voglibose delays carbohydrate absorption in the intestine, reducing postprandial glucose spikes.
Together, they provide comprehensive glycemic control in adults inadequately controlled on single or dual therapy.
Uses:
-
Type 2 Diabetes Mellitus (T2DM)
-
Glycemic control in patients not controlled on monotherapy or dual therapy
Benefits:
-
Controls both fasting and postprandial blood sugar
-
Reduces the risk of diabetes-related complications
-
Convenient once or twice daily dosing
-
Targets multiple mechanisms of diabetes
Composition (per tablet):
-
Metformin Hydrochloride – 500 mg
-
Glimepiride – 2 mg
-
Voglibose – 0.2 mg
Side Effects:
Common:
-
Hypoglycemia (low blood sugar)
-
Nausea, vomiting
-
Flatulence, diarrhea
-
Dizziness
-
Abdominal discomfort
Serious (rare):
-
Lactic acidosis (from Metformin – rare but serious)
-
Severe hypoglycemia (especially with missed meals)
-
Liver enzyme changes
Safety Advice:
-
Take with meals to reduce gastrointestinal side effects
-
Monitor blood glucose levels regularly
-
Not recommended in type 1 diabetes or diabetic ketoacidosis
-
Avoid alcohol as it may increase the risk of lactic acidosis or hypoglycemia
-
Use cautiously in patients with kidney or liver impairment
-
Store in a cool, dry place
-
Keep out of reach of children
